ABION Inc. (KOSDAQ:203400)
South Korea · Delayed Price · Currency is KRW 2,495.00
-55.00 (-2.16%)
At close: Apr 24, 2026
ABION Market Cap
ABION has a market cap or net worth of 224.8 billion as of April 24, 2026. Its market cap has increased by 28.48% in one year.
Market Cap
224.80B
Enterprise Value
196.47B
Revenue
880.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,495.00
Market Cap Chart
Since April 5, 2017, ABION's market cap has increased from 54.88B to 224.80B, an increase of 309.60%. That is a compound annual growth rate of 16.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 224.80B | -20.29% |
| Dec 30, 2025 | 282.02B | 40.69% |
| Dec 30, 2024 | 200.46B | 22.52% |
| Dec 28, 2023 | 163.61B | 29.00% |
| Dec 29, 2022 | 126.83B | -53.68% |
| Dec 30, 2021 | 273.81B | 220.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| curacle co.,ltd. | 340.86B |
| TiumBio | 307.07B |
| NIBEC | 305.79B |
| Bio Solution | 281.01B |
| Genome & Company | 214.24B |
| ISU Abxis | 202.83B |
| ViGenCell | 196.79B |
| Prestige Biologics | 193.60B |